Friday, 6. November 2026 · Next update: 10:00 DE EN Log in
Cassandra.news
Tomorrow's news. Today.
📈 Economy · Next Week

AstraZeneca plc (LSE: AZN) beats the adjusted core EPS consensus of approx. USD 5.05 per share in its H1-2026 results (27 July 2026)

Hit ✦ AI-generated prediction Published on 20. July 2026 · Predicted for 27. July 2026 · Based on: Historical Cycle
Probability
67%

AstraZeneca beat in Q1 2026 with core EPS of USD 2.58 vs. consensus USD 2.52 (+2.4%) and beat the revenue consensus at USD 15.29B (+13% YoY). Drivers: Oncology (Tagrisso, Imfinzi, Enhertu) and Rare Disease. H1 consensus is approx. USD 5.05; AZN has beaten EPS in each of the past six quarters. No Polymarket contract; calibrated from earnings-beat streak and pipeline strength.

Data basis for this prediction
  • AstraZeneca Q1 2026: Core-EPS 2,58 USD vs. Konsens 2,52 USD, Umsatz 15,29 Mrd. USD +13 % YoY (businesswire.com, 29.4.2026)
  • AstraZeneca H1 2026 Ergebnistermin: 27. Juli 2026 (AZN IR-Kalender)
  • H1 2026 Konsens-Core-EPS ca. 5,05 USD (Yahoo Finance / TipRanks, Stand 20.7.2026)
  • AstraZeneca Onkologie-Pipeline: 5 Blockbuster mit kombiniertem Wachstum >15 % YoY (Q1 2026)

Note: This is an AI-generated statistical forecast for entertainment and information purposes. It does not constitute investment advice or a recommendation to buy or sell any financial instrument.

Verdict: Hit
[Vorzeitig entschieden] AstraZeneca H1 2026 (veröffentlicht 27. Juli 2026): bereinigter Core-EPS von $5.21 – übertrifft den Konsens von ~$5.05. Quelle: BusinessWire (AZN-Pressemitteilung), StockTitan, DirectorsTalkInterviews
Related Predictions
📈 Economy ✦ AI

S&P 500 (SPX) closes above 7,500 on Friday, 13 November 2026 (confirmed via NYSE closing price or Bloomberg by 14 November 2026, 10:00 ET)

The S&P 500 dropped 4.36% on 5 November 2026 to 7,353.73 — its steepest one-day fall since April 2025 — triggered by an AI-chip selloff that wiped out the post-midterm rally (4 November: +1.72% to 7,698.80). Closing above 7,500 by 13 November requires a +2.0% recovery over 6 trading sessions. Goldman Sachs, Morgan Stanley and JPMorgan maintain year-end targets of 7,400–8,100; S&P 500 EPS growth consensus for 2026 stands at +14% YoY. Downside risks: elevated Treasury yields, persistent AI capex uncertainty. No specific Polymarket/Kalshi market found for this level.

62%
Next Week · Predicted for 13. Nov 2026
📈 Economy ✦ AI

US Consumer Price Index (headline CPI) for October 2026 exceeds 3.7 percent year-on-year — BLS release November 10, 2026, 8:30 AM ET (confirmed by BLS or Bloomberg by November 10, 2026, 10:00 AM ET)

The BLS releases October 2026 CPI on November 10, 2026 at 8:30 AM ET. Nowflation forecasts 3.82 percent YoY; the Cleveland Fed nowcasting model forecasts 3.74 percent — both clearly above the 3.7 percent threshold. The September 2026 prior reading was exactly 3.7 percent. Rising energy prices (Strait of Hormuz effectively closed since mid-October) and stable core inflation support a further uptick. An existing open platform prediction covers CPI >3.5%; this forecast raises the bar by 20 basis points. A miss would primarily require unexpected weakness in the energy component or food prices.

65%
Next Week · Predicted for 10. Nov 2026
📈 Economy ✦ AI

Gold (XAU/USD Spot) closes above $4,400 per ounce on 31 December 2026 (confirmed by Bloomberg or Kitco by 1 January 2027)

Gold (XAU/USD) rose to $4,134.83 on 5 November 2026 — driven by the Democratic midterm sweep (higher fiscal spending expected) and persistent inflation pressure. Kalshi's Dec 31 settlement market shows ~32% probability for a close above $4,400 and ~43% for above $4,300. Reaching the $4,400 year-end target would require a further ~6.4% gain. Supporting factors: fiscal expansion, geopolitical risks, structurally high central bank demand; UBS forecasts $4,800, JPMorgan $6,000 at year-end. Headwind: hawkish Fed stance (Polymarket: 72.5% for a December rate hike to 4.00–4.25%). Prediction anchors on Kalshi's ~32% for >$4,400.

32%
Next Year · Predicted for 31. Dec 2026